During Drosophila neuroblast lineage development, temporally ordered transitions in neuroblast gene expression have been shown to accompany the changing repertoire of functionally diverse cells generated by neuroblasts. To broaden our understanding of the biological significance of these ordered transitions in neuroblast gene expression and the events that regulate them, additional genes have been sought that participate in the timing and execution of these temporally controlled events. To identify dynamically expressed neural precursor genes, we have performed a differential cDNA hybridization screen on a stage specific embryonic head cDNA library, followed by wholemount embryo in situ hybridizations. Described here are the embryonic expression profiles of 57 developmentally regulated neural precursor genes. Information about 2389 additional genes identified in this screen, including 1614 uncharacterized genes, is available on-line at 'BrainGenes: a search for Drosophila neural precursor genes'
Introduction
During Drosophila neurogenesis, central nervous system (CNS) precursor cells, called neuroblasts (NBs), are singled out from adjacent neuroectodermal cells by a cascade of regulatory events involving both cell intrinsic and extrinsic signals (for review see Campos-Ortega, 1995; Skeath, 1999) . Commencing soon after gastrulation, NBs exit the neuroectoderm (NE) and initiate lineage development in the subepidermal proliferative zone by cycling through a series of 5-15 asymmetric divisions producing a ganglion mother cell (GMC) with each event. Each GMC divides once to yield either neurons or glia (for review see Fuerstenberg et al., 1998) . The molecular events that regulate cell-fate decisions during neural lineage development in insects or in vertebrates are only partially understood (reviewed by Anderson and Jan, 1997; Edlund and Jessell, 1999; Jurata et al., 2000) .
Underpinning the formation of Drosophila NB lineages are spatially and temporally regulated transcription factor networks that play pivotal roles in establishing the unique cellular and temporal identities of NBs and their progeny.
For example, previous work by others (see review by Arendt and Nübler-Jung, 1999) has shown that prior to NB delamination, during the initial specification of NBs, two spatially regulated transcription factor networks subdivide the ventral NE along its anterior/posterior (A/P) axis and dorsal/ventral (D/V) axis. Mutational analysis reveals that integrated A/P and D/V regulatory networks function to determine the unique identity of each NB prior to its entry into the subepidermal proliferative zone (Bhat and Schedl, 1997; Chu et al., 1998; McDonald et al., 1998; Weiss et al., 1998) .
At least two additional gene expression programs are initiated during or after the A/P-and D/V-axis networks have established NB identities. First, a temporal NB network controls the identities of different GMCs and their neurons or glia during NB lineage development, and second, cell-type specific gene expression programs oversee the cellular progression from NB ! GMC ! neuron/glia. The temporal identities of sequentially formed basal (inner or dorsal) to apical (outer or ventral) neuronal subpopulations have been shown to be controlled in part by members of the temporal transcription factor network (Kambadur et al., 1998; Brody and Odenwald, 2000; Isshiki et al., 2001) . The second process, the progression NB ! GMC ! neuron/glia is regulated by factors that control asymmetric cell divisions (reviewed by Matsuzaki, 2000) .
Regulatory networks that govern the expression, post-translational modification and subcellular distribution of Prospero, Inscuteable and Numb are most likely linked to these cellular events.
To learn more about the regulatory networks that control cell-identity decisions after the initial specification of NB identities, we have searched for additional genes that are dynamically expressed during the formation of neural lineages. In order to identify genes that may otherwise be missed in morphologically based mutant screens, a wholemount embryo in situ hybridization screen was performed on differentially expressed genes identified in a stage 11 embryonic head cDNA library (Fig. 1) . During this phase of CNS development, the embryonic head contains a relatively large heterogeneous population of NBs actively undergoing different phases of lineage development.
In this report, we describe the embryonic CNS expression dynamics of 57 genes whose nervous system expressions have not been previously characterized. To date, only 19 of the 57 genes have been partially characterized in the literature. Most have been predicted by the Drosophila genome project (Adams et al., 2000) ; a few have already been cloned, but some are undefined, that is, they are not among the genes predicted by the Drosophila genome project. Also, we provide information on an additional 813 known and 1576 previously uncharacterized genes whose corresponding cDNAs have been identified in the screen. Information about all of the genes is available on-line at 'BrainGenes: a search for Drosophila neural precursor genes' (http:// sdb.bio.purdue.edu/fly/brain/ahome.htm).
Results and discussion
In order to identify genes expressed temporally during embryonic CNS development, a whole-mount embryo in situ hybridization screen was performed on differentially expressed genes identified in a stage 11 embryonic head cDNA library. This developmental window was chosen because it represents mid-neurogenesis. At this time, distinctly defined sublineages are being generated from all active NBs.
Single-pass 5 0 DNA sequencing performed on 4337 cDNAs retained after the negative selection (0.4% of the approximately 1:08 £ 10 6 screened colonies) identified 2446 genes. A measure of the efficacy at avoiding ubiquitously expressed genes is indicated by the low frequency of isolation of cDNAs corresponding to highly expressed genes such as ribosomal protein L32 (RP49), one isolate; actin 5C, two cDNAs, and actin 88F, no isolates. In addition, only 19 of the selected plasmids lacked cDNA inserts. Among the 832 previously characterized genes, i.e. those that have been described in the literature, many encode developmentally regulated transcription factors, chromatin-binding proteins, RNA-binding proteins, components of intracellular signaling pathways, transmembrane (TM) receptors, ligands, or extracellular matrix proteins. Information on all of the genes identified in the screen can be obtained at the web site 'BrainGenes: a search for Drosophila neuronal precursor genes' (http://sdb.bio.purdue.edu/ fly/brain/ahome.htm). Both characterized and uncharacterized genes are displayed according to the presumed func- Fig. 1 . A differential cDNA expression screen for neural precursor genes. (A,B) Collection of stage 11 Drosophila embryo heads. Embryo heads were manually pushed out of the embryo chambers, dissected free of the embryo carcass, and pooled for RNA isolation. (A) Shown is a Castor immunostained stage 11 embryo head protruding from its embryo chamber (during this stage of embryonic development, Castor protein is found in NBs and GMCs). Note, due to the hydrophobic nature of the vitelline membrane (arrowhead), the remainder of the enclosed embryo is not immunostained. (B) Castor immunostained carcass, after removal of its head and surrounding vitelline membrane. (C) Differential cDNA screen and high throughput embryo in situ hybridization strategy to identify novel neural precursor genes. tion(s) of their encoded proteins. Genes that have not yet been functionally characterized were grouped according to their shared protein domain homologies with proteins of known function. Those genes whose predicted proteins do not contain significant homologies with other known proteins were classified as novel. Presented for each gene is the Celera 'CG' number and links to GadFly, the genome annotation database of Drosophila (http://hedgehog.lbl. gov:8001/annot/). The GadFly link provides information on the gene and its encoded protein such as the availability of corresponding cDNAs in the Berkeley Drosophila Genome Project (BDGP) database, the level of protein homology to identified proteins of other species, and the availability of P-element insertion lines. Selected transcription factors and signaling proteins, both characterized and uncharacterized, are listed in Tables 1 and 2 , respectively.
To study the expression patterns of those genes whose embryonic expressions are currently unknown or have not been fully studied, we next carried out whole-mount in situ hybridizations using 0-18-h-old embryos. This report describes the expression dynamics of 57 genes that are expressed in the developing nervous system (see Table 3 and Figs. 2-7). These genes include previously characterized genes for which the CNS expression dynamics have not been completely described. The number of cDNAs identified that correspond to each of these genes is given in Table  3 . For comparison, the number of cDNAs identified by the BDGP is also provided (Rubin et al., 2000) . Starting with nuclear factors, our findings are arranged according to the predicted cellular locations of the encoded proteins. These categories include cytosolic proteins, TM proteins, and extracellular proteins. Selected for illustrations are subsets of gene expression profiles that are the most informative, and not illustrated are those gene expression patterns for which verbal descriptions are adequate.
Genes coding for nuclear factors
Of a total of 2446 genes uncovered in the screen, cDNAs corresponding to 221 putative or known transcription factor genes were identified (Table 1) . These include: (1) 19 homeobox genes (all but four have been characterized previously); (2) 12 basic helix-loop-helix proteins, including four that have not been characterized; (3) 80 zinc finger proteins (only 18 have been functionally characterized); and (4) thirty-three additional transcription factors that contain other DNA-binding domains such as T-box domains (three identified) and HMG domains (three identified). Of these 33 putative transcription factor genes, 16 have not previously been characterized.
The differential expression screen also identified cDNAs corresponding to 96 putative or known genes coding for chromatin-associated proteins, including proteins implicated in cell cycle regulation. The chromatin proteins included Trithorax and Polycomb complex genes (reviewed by Pirrotta, 1998) , as well as genes associated with dosage compensation (Pannuti and Lucchesi, 2000) . The cell cycle regulators included string, cdc2, cdc2-related-kinase, cyclin A1, Cyclin D, cyclin-dependent kinase subunit, and Dacapo. A full list of these genes with the frequency of their identification is available at the BrainGenes website.
Of the nuclear factors, our embryo in situ hybridization analysis of their expression has identified 15 uncharacterized or partially characterized genes that are dynamically expressed during nervous system development (Tables 1  and 3 and Fig. 2) . Many of these genes exhibit lineage specific, cell-type specific, and/or temporally restricted expression patterns (described below).
Transcription factors expressed in subsets of NBs and their progeny
Of the nuclear factors, four genes exhibit mRNA expression in a limited number of NBs and their progeny. The first of these, CG10016, encodes a zinc finger protein named drumstick (drum: R. Green and J. Lengyel, personal communication). The drum gene is part of a zinc finger gene complex that includes odd-skipped (Coulter et al., 1990) . drum mRNA is first detected in seven segmental bands with the most posterior stripe being the broadest ( Fig. 2A) . During gastrulation the seven segmental bands resolve into 15 stripes (data not shown). By full germ-band extension, expression fades in these stripes such that only a single NB per hemisegment contains detectable message (Fig. 2B ). Also note, drum mRNA is expressed in both the anterior and posterior gut invaginations. The second gene, CG9403, also encodes a C 2 H 2 zinc finger transcription factor. Neural expression of CG9403 is first detected in late stage 11 embryos in a subset of cells distributed throughout the cephalic lobes. At this time CG9403 is also expressed in a subset of ventral cord midline cells and this expression persist through stage 14 (Fig. 2C ). Based on their position in the developing midline and the morphology of their cell bodies, these cells are likely to be midline glia. CG9403 positive cells in the brain are also likely to be glial. The third gene, fork head domain 96Cb ( fd96Cb) is one of two closely linked Fork head protein-encoding genes (Hacker et al., 1992) . Although the expression of this gene has been described in the Hacker publication, our in situ hybridization reveals additional complexity of its CNS expression ( Fig. 2D-F) . fd96Cb expression is first detected in a single medial-column ventral cord NB and adjacent GMCs. Soon after, three additional NBs in the lateral column of each ventral cord hemisegment activate expression. Expression in the lateral NB lineages is transient such that by late stage 12, only the medial NB and one lateral NB maintain high steady state mRNA levels. The fourth gene, CG6634, is a T-box transcription factor termed H15 (Porsch et al., 1998) . CNS expression of an H15-LacZ reporter has been described (Griffin et al., 2000) . Within the developing nervous system, our in situ hybridization analysis reveals that CG6634 transcripts are first detected during late stage 
Zn finger homeodomain 2 (2) CG6256 CG10309 CG17912 NK7.1 Fig 12 embryos in a single neuron per hemisegment (data not shown).
Transcription factor-coding genes exhibiting celltype specific neural expression
Six transcription factor-encoding genes exhibited celltype specific neural expression. Four of these are zinc finger genes; nervous fingers 1 (nerfin-1), CG7372, Kruppel homolog 1 (Kr-h1), and CG6930. We have previously described the expression of the first of these genes, coding for the zinc finger transcription factor Nerfin-1 (Stivers et al., 2000) . nerfin-1 mRNA is transiently expressed in all early NBs, however, during late sublineage development nerfin-1 transcripts are detected only in GMCs and nascent neurons (Stivers et al., 2000) . A second zinc finger transcription factor gene, CG7372, encodes a structural homolog of the human ZNF45 protein (Constantinou Deltas et al., 1996) . CG7372 mRNA is expressed in most, if not all, CNS GMCs and PNS sensory organ precursors (SOPs) (Fig. 2G ). It is also maternally expressed, however, there is a marked reduction in steady state mRNA levels during gastrulation. Mutants of a third zinc finger encoding gene, Kr-h1, fail to complete head eversion (Pecasse et al., 2000) . The expression pattern of Kr-h1, based on in situ hybridization, has been reported (Schuh et al., 1986) . Our expression analysis reveals that in addition to the previously reported expression, Kr-h1 is also expressed in most if not all neurons of the CNS and PNS starting at stage 12 (Fig. 2H) . A fourth zinc finger gene, CG6930, initiates expression in the ectoderm prior to CNS development. Expression persists only in the developing nervous system, such that by stage 13, transcripts were observed in a subset of CNS and PNS neurons (Fig. 2I) .
A fifth transcription factor exhibiting cell-type specific expression, Myb oncogene-like (Myb), has been shown to be required for both mitosis and prevention of endoreduplication in wing cells (Katzen et al., 1998) . In addition to the maternal expression described by Katzen and Bishop (1996) , we observe that Myb is zygotically expressed in most if not all GMCs, however, expression is not detected in post-mitotic neurons (data not shown). A sixth transcription factor-encoding gene exhibiting cell-type specific expression, DNA replication-related element factor (Dref ), has been shown to be required for normal DNA replication in both the mitotic cell cycle and endocycle (Hirose et al., 1999) . In addition to the early expression noted by Yamaguchi et al. (1995) , our in situ hybridization studies also reveal that Dref transcripts are expressed in neural precursor cells of the CNS (including NBs and GMCs) and in SOPs of the PNS (data not shown).
Genes encoding cell cycle regulators
Four genes coding for proteins that may function to regulate cell cycle progression have been identified in our in situ hybridization study. Besides Dref (described above), the three cell cycle regulators are Minichromosome maintenance 7 (Mcm7), CDC45L, and Set (references provided below). Previous work has shown that Mcm7 mRNA levels are high in unfertilized eggs and early embryos (0-4 h after fertilization), and then they decrease gradually, with only low steady state levels detected at later stages of development (Ohno et al., 1998) . Mcm7 mRNA is also reported to be expressed in the developing CNS (Feger, 1999) . In addition to the maternal and early embryonic expression noted by Ohno et al., 1998 , our in situ hybridizations reveal that Mcm7's CNS expression is restricted to most, if not all, NBs (Fig. 2J) , and by stage 15, expression is detected in only a subset of cephalic lobe NBs. CDC45L has been described by Loebel et al., 2000. Our in situ hybridization studies show that zygotic CDC45L expression is observed in NBs, both during early and late lineage development (Fig. 2K) . At stage 13, transcripts are detected only in the proliferative zones of each of the developing ganglia, and by stage 14 no expression is detected. Mammalian Set domain proteins have been implicated in regulation of histone deposition (Adams and Kamakaka, 1999) and have been shown to interact specifically with B-type cyclins (Kellogg et al., 1995) . Drosophila Set mRNA is maternally expressed, and transcripts are detected throughout the embryo during gastrulation (data not shown). Onset of zygotic expression is detected at stage 10 in NBs. By stage 13, there is a marked reduction in expression throughout the nervous system; by stage 14 there is no detectable expression in the embryo. The stage specific expression of multiple chromatin associated proteins and cell cycle regulators in the CNS indicates that their functions during neurogenesis may be temporally controlled.
Genes encoding chromatin associated proteins
Two genes encoding potential chromatin associated proteins were identified in our screen. CG9135 codes for a putative chromatin associated protein that is likely to serve as a guanine nucleotide exchange factor, with a potential function in protein transport and/or chromatin structure. CG9135 is maternally expressed, and zygotic expression is detected in GMCs throughout the ventral cord and cephalic lobes (data not shown). From stage 12 to 14 CG9135 mRNA is pan-neurally expressed both in precursor cells and in nascent neurons. The second chromatin-associated protein, D1 chromosomal protein (Ashley et al., 1989) , is a member of the HMGI/Y family of DNA-binding proteins. Our in situ hybridization confirms that D1 is maternally expressed (Renner et al., 2000) , and by stage 10 increased levels of expression are seen in GMCs (data not shown). Starting at stage 13 there is a marked reduction in expression throughout the nervous system such that by stage 14 no transcripts are detected. Continued expression in the CNS following ubiquitous embryonic expression suggests that this expression is related to universal regulatory functions required in all cells, with a persistent need derived from the continuation of CNS cell divisions after the exit of non-CNS cells from the cell cycle earlier in development.
RNA-binding proteins
Exclusive of cDNAs corresponding to general translational machinery, cDNAs that were largely eliminated by the negative selection, 94 uncharacterized or known genes coding for RNA-binding proteins were identified in our screen. Among the genes identified were those coding for the following proteins involved in CNS development: Adenosine deaminase acting on RNA (Adar), Embryonic lethal abnormal vision (Elav), Heterogeneous nuclear ribonucleoprotein at 27C, Mushroom-body expressed, and Split ends.
Described below are four additional genes coding for RNA-binding proteins (see Table 3 and Fig. 3): (1) CG10668, whose predicted protein most closely resembles the mammalian protein RBMS3 (Penkov et al., 2000) ; (2) the previously characterized Heterogeneous nuclear ribonucleoprotein at 87F (Hrb87F: Haynes et al., 1991) which corresponds to CG12749; (3) the previously identified fne (Lasko, 2000) , and (4) CG11886, a homolog of the vertebrate histone stem-loop-binding protein (Whitfield et al., 2000; Sullivan et al., 2001) . CG10668 is transiently expressed outside the CNS in a sheet of cells just posterior to the anterior gut invagination on the ventral side of the embryo during germ-band extension (Fig. 3A) . By stage 11, CG10668 is expressed in a subset of ventral cord midline cells and two putative GMCs per hemisegment (Fig. 3B, C) . Both Hrb87F and CG11886 are maternally expressed, with transcripts persisting in GMCs and neurons of the CNS (Fig.  3D and data not shown). Fne is zygotically expressed, with transcripts restricted to neurons in the developing CNS and PNS (Fig. 3E) . The non-lineage specific expression of each of these four RNA-binding proteins suggests widespread neural specific functions similar to those found for Elav (reviewed by Yao et al., 1993) . 
Cytoskeletal and intracellular signaling proteins
cDNAs corresponding to 97 putative and known genes coding for cytoskeletal proteins were identified in our screen. cDNAs corresponding to 303 genes coding for signaling proteins were also identified. The characterized signaling protein-encoding genes that are known to be expressed in the CNS are detailed in Table 2 , in addition to selected genes coding for uncharacterized signaling proteins. Included in this category are genes coding for scaffolding proteins. For comprehensive references of the characterized genes, see FlyBase (http://flybase.bio.indiana.edu/). For a complete list of genes coding for both signaling proteins and cytoskeletal proteins, see the BrainGenes website. For most of these genes, the frequency of cDNAs identified in our screen was low (one or two per gene). However, there were two exceptions: failed axon connections and miranda were identified over ten times each.
Cytoskeletal proteins
Described below are two genes coding for cytoskeletal proteins and six genes coding for putative signal transduction proteins (Table 3 and Fig. 4) . We identified genes coding for Drosophila homologs of tensin and talin, and have shown that their mRNAs are expressed in the developing CNS, albeit in patterns that differ one from another. Vertebrate tensin and talin are components of focal adhesion complexes (reviewed by Yamada and Geiger, 1997) . During embryonic development, the Drosophila talin gene (CG6831) expression is restricted to a subset of neurons (Fig. 4A-C) . Its expression is first detected in a subset of medial ventral cord neurons (Fig. 4A) . By stage 13 (Fig.  4B) , expression is also detected in neurons that occupy intermediate and lateral positions in the ventral cord and in the midline, and by stage15 (Fig. 4C) , expression is detected in neurons that flank the midline and clusters of lateral neurons in the ventral cord and in a subset of neurons in the cephalic lobes. In contrast to Talin, Tensin (CG9379) is maternally expressed, then zygotically in the NE and finally in a subset of NBs (Fig. 4D ). Except for a novel Cterminal domain, amino acid sequence homology with talins of other species is found throughout the predicted Drosophila protein. BLAST data base searches reveal that the Cterminal region of Drosophila Tensin, shares homology with the C-terminal domain of mammalian tensin .
Signal transduction proteins
Six genes coding for signal transduction proteins were identified in our screen as being expressed in the CNS (Tables 2 and 3): (1) CG3427, a putative guanine nucleotide exchange factor that also possesses a cAMP-binding domain; (2) mab-2, a homolog of a C. elegans gene that has been implicated in regulating the hypodermal versus NB cell-fate choice (Chow et al., 1995) ; (3) dappled (Rodriguez et al., 1996) , whose C. elegans homolog, LIN-41 (48% identity), is a heterochronic gene, encodes a protein with an N-terminal C 3 HC 4 RING finger motif. Mutations in dappled trigger precocious expression of adult fates at larval stages (Slack et al., 2000) ; (4) CG7324, encoding a potential GTPase-activator resembling Drosophila Pollux (Zhang et al., 1996; Xu et al., 1998) ; (5) CG11754, encoding a homolog of DOCK180, a CRK-binding protein implicated in signal transduction (Hasegawa et al., 1996) , and (6) Segregation distorter (Sd), encoding a RanGAP nuclear transport protein (Merrill et al., 1999) . Three of these genes are expressed in subsets of cells: CG3427 in ventral cord midline glia (Fig. 4E ) and mab-2 and CG7324 both expressed in subsets of neurons ( Fig. 4F and data not shown). mab-2 expression is detected in a subset of ventral cord neurons and in putative midline neurons. CG7324 expression is first detected in the cellular blastoderm in eight segmental stripes that are excluded from the presumptive mesoderm. By germ-band extension there are 13 stripes in the ventral neurogenic region, and soon after, at stage 9, expression is restricted to a subset of NBs that presumably originate for these segmentally arrayed neuroectodermal expression domains. In stage 14 and older embryos, low levels of expression are detected in ventral cord midline cells. The other genes coding for signaling proteins (dappled, CG11754, and Segregation distorter) are maternally expressed; however, later in development the expression of these genes is detected only in the CNS (Fig. 4) . dappled mRNA is detected in NBs, GMCs, and neurons (Fig. 4G) . Low levels of expression are also detected in a subset of putative PNS neurons. dappled transcripts are also found throughout the embryo; however, higher levels of transcript are detected in GMCs and nascent neurons of the CNS (data not shown). Segregation distorter (Sd) mRNA is detected in CNS NBs and by stage 14, expression is no longer detected (data not shown).
Enzymes and chaperones
Our screen identified 246 genes coding for enzymes and 53 genes coding for chaperones; the expression dynamics of six of these genes (Table 3 and Fig. 5 ) are described below. Five of the six are temporally activated in NBs or GMCs: Ecdysone-inducible gene L3 (ImpL3, encoding a lactate dehydrogenase), CG4446 (encoding a pyridoxal kinase), CG1444 (encoding a steroid methyltransferase), CG5358 (encoding a homolog of the mammalian Coactivator-associated arginine methyltransferase 1 that targets nuclear receptors: Chen et al., 1999) , and CG5235 (a dopamine beta-hydroxylase). Of these five, all but one (ImpL3) are maternally transcribed, but their transcription is also reactivated during neurogenesis. Of the six genes in this group, expression of only one gene, Calnexin 99A, is activated in a lineage-restricted manner.
The embryonic expression of ImpL3, has been partially characterized (Abu-Shumays and Fristrom, 1997). We have detected additional temporal phases of ImpL3 expression (Fig. 5A-C) . Following expression in the anterior tip of the cellular blastoderm (Fig. 5A) , ImpL3 transcripts are detected in most, if not all, early delaminating NBs (Fig. 5B) .
However, by stage 11 only two adjacent NBs within each ventral cord hemisegment express ImpL3 (Fig. 5C ). ImpL3 mRNA is also detected in single midline cell (Fig. 5C ). However, during stage 10, NB expression disappears. As noted by Abu-Shumays and Fristrom (1997), ImpL3 expression is next activated in the lateral musculature during stage 13. Expression of the second temporally activated gene, CG4446, is activated in most, if not all, NBs during late sublineage development (Fig. 5D) . However, no expression is detected in GMCs or neurons. Zygotic expression of the third temporally activated gene, CG1444, is detected in a subset of GMCs throughout the CNS and later expression is detected at a low level in post-mitotic neurons (Fig. 5E) . Outside of the CNS, starting at stage 14, expression is detected in six clustered large cells within the first seven abdominal segments. The CG1444 expressing cell clusters are located midway between the dorsal and ventral midlines, just underneath the epidermis (data not shown). Zygotic expression of the fourth of these genes, CG5358, is activated during stage 8 in NBs; transcripts are also detected in GMCs during late sublineage development (Fig. 5F ). Low levels of CG5358 mRNA are detected in neurons. Expression of the fifth temporally activated gene, CG5235, is detected in NBs and GMCs, however, no expression is detected in neurons. During stage 13, transient expression can also be detected in secondary SOPs of the PNS (data not shown). Calnexin 99A, the sole lineage specific gene in this group, is highly related to its mammalian counterpart, and there are four Drosophila isoforms, coded for by separate genes; only two isoforms have been characterized (Christodoulou et al., 1997) . In the CNS Calnexin 99A expression is restricted to longitudinal and midline glia (Fig. 5G) . Expression is also detected in cells lining the developing gut.
Genes coding for cell surface proteins
Included in this class are genes coding for TM and secreted proteins cDNAs representing 72 known or putative receptors were also identified in the screen. Known TM receptors identified include Baboon, Breathless, Capricious, Commissureless, Derailed, Delta, Eph tyrosine kinase, Fasciclin 3, Fasciclin II, Flamingo, Frazzled, Gliolectin, Gliotactin, Myospheroid, Neuroglian, Neurotactin, Notch, Ror, Roundabout 1, Saxophone, and Tartan. cDNAs corresponding to eight known or putative channel proteins were also isolated in the screen, including Innexin 3, Inx2, Na channel protein 60E, Optic ganglion reduced, and Shaker cognate l. In addition to the above TM protein-encoding genes, genes corresponding to 62 other putative or known TM proteins were isolated (links to the GadFly database are provided in BrainGenes for all of these genes). Our screen also identified 37 genes coding for known or putative extracellular proteins. Known ligands and extracellular matrix proteins include Amalgam, Decapentaplegic, Ephrin, Glutactin, Lachesin, Laminin A, Laminin B1, Laminin B2, Netrin-A, Plexin A, Roughest, Sema-1b, Sema-2a, The embryonic expression dynamics of eleven of the uncharacterized genes coding for putative extracellular or TM proteins are described here (Table 3 and Fig. 6 ). These are divided into two groups, those that are expressed in subsets of cells in the CNS, and those that exhibit celltype specific activation of transcription, that is, they are activated in the NE, NBs, GMCs, or neurons; in addition, one is expressed in macrophages that envelop the CNS.
Genes coding for surface proteins expressed in subsets of cells
Four genes encoding cell surface proteins, CG13986, CG2893, CG5670, and CG18111 were expressed in subsets of cells in the CNS. (1) CG13986 encodes a novel protein containing two putative TM domains. (2) CG2893 encodes a putative sodium/calcium exchange protein whose sequence is homologous to a number of similar proteins in Drosophila -CG1090, CG17167, CG12061, and CG4106. The only member of this family that has been characterized thus far is CG5685, which corresponds to the Calx Na/Ca-exchange protein (Schwarz and Benzer, 1997) . (3) CG5670 corresponds to the previously characterized Na pump a-subunit gene (Lebovitz et al., 1989) . (4) CG18111 codes for a member of the PBP/GOBP family of pheromone-and odorant-binding proteins (see Pelosi and Maida, 1995) .
CG13986 mRNA is detected at stage 10 in a single medial NB per hemisegment, and during stage 11, expression is detected in a subset of CNS neurons (Fig. 6A ). This neural expression follows earlier expression in cells that line the segmental invaginations within the epidermis and in the gut. Zygotic expression of CG2893, coding for the sodium/ calcium exchange protein, is first detected in stage 13 embryos in a subset of cells in both the CNS and PNS. Based on its expression in stage 14 and older embryos, these cells appear to be a subset of glial cells (Fig. 6B, C) . Expression of the gene encoding Na pump a-subunit (CG5670) has been characterized using a monoclonal antibody to the avian Na pump a-subunit (Lebovitz et al., 1989) . Our description supplements this published information by providing temporal information on the mRNA expression. Expression is first detected at midstage 12 in a subset of neurons that flank the ventral cord midline (Fig.  6D) . By stage 13, expression is detected in a subset of flanking neurons, and by stage 14, expression is detected in a subset of lateral neurons and a subset of neurons in the PNS, including the antenno-maxillary complex. CG5670 is also expressed in a subset of neurons in the cephalic lobes. Expression is confined to the nervous system. The odorant-binding protein-encoding gene, CG18111, is segmentally expressed in the NE following gastrulation, at stage 7 (Fig. 6E) . During stages 7-13 there is a segmental pattern of expression in 13 stripes in the NE and in the head region.
Ventral cord NBs that underlie the segmental stripes also express CG18111. Expression is also detected in a subset of head NBs, however, no expression is detected in GMCs or neurons.
Genes coding for surface proteins exhibiting cell-type specific expression
Seven of the TM/secreted protein-encoding genes exhibit cell-type specific activation of transcription. (1) CG10577 codes for a sec7 domain protein that is related to the human KIAA0763 protein. Sec7 domain proteins have been shown to be involved in intracellular vesicular trafficking in other model systems (reviewed by Jackson and Casanova, 2000) . (2) Tollo (CG6890), also referred to as Toll-8, shares a cytosolic Toll/IL-1R homology (TIR) domain with the Toll-like receptors (Tauszig et al., 2000) . (3) CG13920 encodes a conserved novel protein, with homologs in fish and humans. Hydrophobicity analysis of the predicted CG13920 reveals four potential TM domains. (4) CG2446 encodes protein that has an N-terminal domain similar to the Arabidopsis protein AAG51077. Within this N-terminal domain, both the Drosophila and Arabidopsis proteins possess a predicted TM region. (5) CG3624 encodes a predicted immunoglobulin domain protein of 168 amino acids that most closely resembles, in length and sequence, Glial growth factor (Marchionni et al., 1993) . (6) CG6151 encodes a protein with three predicted TM domains. (7) CG16876 codes for a receptor-like protein with four EGF domains and a single TM domain.
Prior to gastrulation, mRNA of CG10577, coding for the sec7 domain protein, is expressed in the lateral neurogenic region, but is excluded from the presumptive mesoderm (Fig. 6F ). There is a central gap in the neuroectodermal expression. During germ-band extension, gene expression is activated in both cephalic and ventral NE regions (Fig.  6G) . Expression is also detected in NBs. After the completion of NB delamination, mRNA levels in the NE decline, and low levels of expression are found in CNS neurons. No expression was observed in the PNS. Tollo expression is first detected in eight segmental stripes in the cellular blastoderm (Fig. 6H) . Each of the expression bands is broader in the neurogenic region than in the presumptive mesoderm. Expression persists during gastrulation, and by germ-band extension, the number of segmental stripes within the NE increases to 15 (Fig. 6I) , with additional expression in the cephalic NE region. No expression was detected in NBs or GMCs. Starting at stage 11, there is a gradual loss of transcripts in the NE: by stage 13, expression is detected only in epidermal segmental invaginations. CG13920 is expressed in NBs and GMCs during late lineage development, and expression persists in neurons. In addition, CG13920 expression is detected in PNS SOPs (Fig. 6J) . However, no expression was detected in PNS neurons. CG2446 is maternally expressed, and higher levels of expression are detected in GMCs and nascent neurons of the CNS (data not shown). During CNS devel-opment, mRNA corresponding to CG3624, which codes for the glial growth factor homolog, is expressed in most if not all GMCs. Later in embryonic development transcripts are detected in lateral skeletal muscle, and by stage 14 in a subset of cells lining the posterior gut (data not shown). CG6151 mRNA expression is first detected in most, if not all, nascent CNS and PNS neurons during germ-band retraction. By stage 15 transcripts are detected in most, if not all, neurons throughout the developing CNS (data not shown).
An additional gene identified in our in situ hybridization screen, CG16876, encodes a receptor-like protein with four EGF domains and a single TM domain. CG16876 is expressed in non-neuronal cells; expression is restricted to macrophages that surround the developing brain and ventral cord ganglia (data not shown).
Genes coding for novel proteins
Novel genes have been categorized into two groups. The first group consists of genes coding for proteins with known motifs but with low homology scores to proteins of other species (74 genes identified) and novel genes that have no predicted homologs in other species (245 genes identified). Group 2, consisting of 65 genes, is made up of cDNAs that do not correspond to the genes predicted by the BDGP; for 47 of these genes, there is no cDNA evidence in the BDGP database. Sequencing of all of these cDNAs revealed that they were generated from polyadenylated mRNA. To ensure that these cDNAs correspond to unique genes, additional BLAST searches were carried out to localize the undefined genes relative to their nearest neighbors (data not shown). In addition, many, but not all, of these cDNAs correspond to cDNAs isolated by the BDGP. Described here are 15 genes coding for novel proteins that show regulated expression in the CNS (Table 3 and Fig. 7) .
Among the genes in the first group, ten previously uncharacterized genes show developmentally regulated expression within the nervous system. Of the genes in the second group, i.e. those that were not predicted by the genome project, four reveal expression in the CNS. Of these four genes, only one, corresponding to cDNA #3929 of our library, is represented by cDNAs in the BDGP database.
Of the 15 genes coding for novel proteins, six are maternally expressed: CG2207, CG5746, CG6520, CG13333, CG18378, and cDNA #2043. Transcripts for four of the maternally expressed genes, CG2207, CG6520, CG18378, and cDNA #2043, were also found in GMCs and nascent neurons. CG2207, corresponding to the gene l(2)k05815 (Spradling et al., 1999) and also termed anon-fast-evolving-1A4 (Schmid and Tautz, 1997) , codes for a protein that is rich in Ala and Glu residues. CG6520 encodes a protein that contains an N-terminus that is rich in glutamine and proline. CG18378 encodes a protein that is novel except for a short stretch of amino acids that resembles two zinc fingers, albeit incomplete. Three genes, CG13333, CG7590, and cDNA #3929 are expressed in subsets of cells in the CNS (see below).
2.6.1. Genes encoding novel proteins exhibiting cell-type specific onset of expression Nine of the genes that encode novel proteins exhibit celltype specific activation of mRNA expression in the NE, NBs, GMCs or neurons. First, cDNA #2043 is detected in NBs and GMCs in the CNS and in SOPs of the PNS (Fig.  7A) . Second, expression of CG2083 (Fig. 7B) is first detected in the ventral NE and transcripts are also found in NBs, GMCs, and neurons of the CNS. CG2083 transcripts are also detected in SOPs and neurons of the PNS and in a subset of cells in the ectoderm at stage 12. However, by stage 13, expression is observed only in the nervous system. Third, expression of CG17724 (Fig. 7C ) is detected in all early delaminating NBs, both in the cephalic neurogenic region and the ventral cord. In addition, the message is detected in GMCs and is short-lived in nascent neurons. CG17724 is also expressed in SOPs of the PNS. Fourth, the CG14042 predicted protein contains a hydrophobic leader peptide and a TM domain. The predicted protein is also rich in glutamine, leucine, and lysine residues. CG14042 transcripts are first detected in NBs during late stage 10, and by stage 15, pan-neural expression is detected in most if not all neurons of the CNS and PNS (Fig. 7D) .
Expression of two of the genes coding for novel proteins, CG9894 and CG18378, is activated in GMCs. The CG9894 predicted protein is novel, but has a nuclear localization signal. CG9894 mRNA is first detected in the CNS in GMCs and in the PNS in secondary SOPs. Expression is detected in most if not all CNS neurons but not in all PNS neurons. By stage 14, CG9894 expression is no longer detected in the lateral PNS, but expression is detected in the antenno-maxillary complex where expression persists through stage 15 (Fig. 7E) . Zygotic expression of CG18378 is found in CNS GMCs and in PNS SOPs. Transcript levels are highest in the nervous system of stage 13 embryos.
CNS expression of three of the novel genes is activated in neurons. CG5746, coding for a protein with a single putative TM domain, is first transiently expressed in the mesoderm of stages 7-8 embryos. Starting at stage 12, neural expression is detected in neurons throughout the CNS and PNS (Fig. 7F) . CG5746 transcripts are also detected in the antenno-maxillary complex starting at stage 13. Expression of the gene corresponding to cDNA #6972 is first detected during stage 12 in CNS neurons and by stage 13, transcripts are detected in most if not all CNS and PNS neurons. Higher levels of expression are detected throughout the CNS of stage 15 embryos (data not shown). Transcription of the gene corresponding to cDNA 5187 is first detected in nascent neurons during early stage 12, and by stage 13 expression is detected in both CNS and PNS neurons. High levels of expression persist through stage 15 (data not shown).
Genes coding for novel proteins exhibiting activation in subsets of CNS cells
We provide here a description of three genes expressed in subsets of CNS cells. CG13333 encodes a predicted protein that has homopolymeric runs of aspartic acid and threonine residues, a region rich in glutamic acid, and an N-terminal hydrophilic region. Starting at stage 9, CG13333 expression is activated in a continuous row of ventral cord midline cells; this expression is maintained until stage 14. During stage 10 and continuing through stage 13, CG13333 transcripts are also detected in a subset of neural precursor cells in the cephalic lobe. Outside of the CNS, CG13333 is expressed in cells that line the tracheal invaginations. CG7590, corresponding to the gene Scylla (GenBank ID: AAF59841), codes for a protein of 280 amino acids. Blast search reveals no significant homologs in other species, and no identifiable motifs, but a paralog termed charybde exists in Drosophila. scylla is not maternally expressed but it is ubiquitously expressed during gastrulation. Expression fades during germ-band contraction: by stage 14, mRNA is detectable in a subset of CNS and PNS neurons. In the ventral cord, transcript is arrayed in a segmental pattern in subsets of neurons; at stage 14, scylla transcript is apparent in six neurons per hemisegment and is also found in a subset of neurons in the cephalic lobe. Transcripts corresponding to cDNA #3929 are first detected at the cellular blastoderm stage in yolk cells. During gastrulation cDNA #3929 transcripts are detected in faint segmental stripes and this expression is subsequently detected in the mesoderm and NE. At stage 10, expression is observed in a subset of ventral cord midline cells and also in a segmental pattern in the epidermis. After stage 13 there is a reduction in the steady state message levels in both the epidermis and ventral cord midline cells.
Summary
In order to enhance our knowledge about the molecular events that control cell-identity decisions during NB lineage development, we have sought to identify and initiate the characterization of novel neural precursor genes. The principle contribution of this report is the description of the CNS embryonic expression dynamics of 57 novel or previously uncharacterized genes. We also provide cDNA evidence of expression in the heads of stage 11 embryos for an additional 2389 genes. Two thirds of these genes (1576) are currently uncharacterized. Although the majority of these genes have been predicted by the Drosophila genome project, our screen has uncovered cDNAs for 65 undocumented genes; 47 of these currently do not have corresponding cDNAs listed in the BDGP database.
The narrow temporal and tissue window of our cDNA screen provides information primarily on the genes expressed during mid-neurogenesis; this information is not readily available in broader based screens that employ cDNA libraries generated from whole embryos and multiple developmental stages. One advantage of selecting a narrow temporal/tissue sample is illustrated by the identification of genes for which there is no previously published expression data, i.e. most of the genes identified in this screen. Our screen identified approximately 60% of the genes listed in FlyBase as possessing embryonic CNS expression profiles. This is a minimum estimate of the depth of our screen since some of the genes identified in FlyBase are activated after 8.5 h. However, the fact that our screen identified known regulators of neural lineage development such as hunchback, POU domain protein 2, and castor (for references see Kambadur et al., 1998; Isshiki et al., 2001 ) either once or twice, but failed to uncover POU domain protein 1, suggests that our search for neural precursor genes was not exhaustive and that additional genes remain to be found. Additionally, these low numbers for known precursor genes, combined with the large number of genes identified, points to the complexity of gene expression during nervous system development.
Of the 57 genes that we identified as displaying temporal expression dynamics in the CNS, 24 initiate zygotic expression in the NE or in NBs. Of these, eight activate transcription in the NE, and only two of these fail to show mRNA perdurance in NBs. Of the 24 early expressors, 11 show mRNA perdurance or de novo expression in GMCs and/or neurons. We identified 14 new genes that initiate transcription in GMCs. Of these eight show perdurance of message and/or new transcription in neurons. Thirteen of the genes identified in this screen initiate expression in neurons and four of the genes display glial specific expression patterns. The mRNA expression data presented in this report will aid future studies aimed at understanding the functional roles that their encoded proteins play in the developing nervous system.
Experimental procedures

Drosophila stocks
Standard Drosophila husbandry protocols were followed in the care, handling, and collection of embryos (Ashburner, 1989) . The stage specific embryonic head cDNA library and 32 P radiolabeled cDNA probes (see below) were prepared from poly-A 1 enriched RNA isolated from embryos of the homozygous viable P[HlacZ] enhancer-trap line (Mellerick et al., 1992) . Whole-mount embryo in situ hybridizations were carried out with overnight embryo collections obtained from Oregon-R flies.
Embryonic head cDNA library
A directionally cloned embryonic head cDNA library (14 million primary recombinants) was prepared from poly-A 1 enriched mRNA isolated from the heads of ,2600 stage 11 embryos. Briefly, 1 h embryo collections were maintained at 238C. After 8.5 h, embryos were dechorionated in 100% Clorox for 3 min, washed three times with Schneider's cell culture medium (GibcoBRL), and then submerged in 750 ml of cell culture medium in a 35-mm petri dish. With the aid of a dissecting microscope, germ-band extended, stage 11 embryos (staging according to Campos-Ortega and Hartenstein, 1985) were identified and transferred via a mechanical pipette (Eppendorf) to fresh 500-ml puddles of cell culture medium. Embryo chambers were opened at the anterior tip of the selected embryos by tearing the vitelline membrane with a curved tungsten needle. Embryo heads were then pushed out of the chamber by applying gentle pressure to the posterior half of the embryo with the curved side of the needle (Fig. 1A) . Immediately following this, the extruded tissue, including the head of the embryo (consisting of the cephalic lobes and gnathal segments), the first thoracic segments, the anterior tip of the anterior gut invagination and salivary gland were separated from the carcass, transferred to a microcentrifuge tube (Eppendorf) in ,10 ml of medium, and snap frozen in liquid nitrogen.
Total RNA was isolated from pooled heads using the 'SNAP' total RNA isolation kit (Invitrogen), and poly-A 1 enriched RNA was selected with oligo dT coated magnetic beads (Life Technologies). cDNA synthesis and the generation of the library were accomplished with standard molecular biology techniques (Sambrook et al., 1989) using the Gubler and Hoffman (1983) cDNA synthesis protocol and the pCMV.SPORT-6 vector (Life Technologies). Singlepass sequencing of 4288 negatively selected clones from the unamplified library (see below) revealed that .99.9% of the clones contained cDNA inserts. In addition, DNA sequencing of both 5 0 and 3 0 cDNA ends of the selected cDNAs failed to detect plasmids that contained more than one cDNA insert.
Differential cDNA library screen
To enrich for genes whose expression was restricted to the developing nervous system and eliminate as many ubiquitously expressed 'housekeeping genes' as possible from our search, we first carried out a negative screen using radiolabeled cDNAs prepared from whole embryos that were not undergoing NB lineage development. Using standard molecular biology bacterial colony hybridization techniques, the unamplified library was screened with a mixture of 32 P radiolabeled cDNAs prepared from 0.5 to 18 h whole embryos (detailed protocols available upon request). Non-hybridizing colonies (0.4% of the library) were picked and re-screened with the above cDNA probes. Purified plasmids isolated from the negative colonies were then subjected to single-pass 5 0 DNA sequencing to identify corresponding genes via database BLAST searches. Although the negative selection eliminated 99.6% of the cDNA clones in the unamplified library, 5 0 cDNA sequence database searches of the negatively selected clones revealed that 16% of these cDNAs corresponded to the developmentally regulated genes Twin of M4 (Apidianakis et al., 1999; Lai et al., 2000) , Amalgam (Seeger et al., 1988) , CG16876, and CG13333 (see below for descriptions of CG16876 and CG13333). To eliminate their repeated isolation in subsequent rounds of negative selection, cDNA probes corresponding to these genes were included in our negative selection cocktail.
Embryo mRNA localization
Overnight (18 h) embryo collections were processed and fixed using standard protocols for mRNA in situ hybridization (Patel, 1994) . Localization of mRNA by whole-mount in situ hybridization was performed according to Kopczynski et al. (1998) , with the exception that the riboprobes were prepared with a labeling mix containing Fluorescein-12-UTP (Roche). Embryonic mRNA expression patterns were revealed using anti-fluorescein Fab fragments coupled to alkaline phosphatase and standard color reactions (Roche). Color development was monitored microscopically, and at the appropriate time the reaction was stopped by washing three to four times with phosphate buffered saline containing 0.1% triton X-100. Stained embryos were mounted in 70% glycerol for observation and in some cases ventral cords were dissected free from embryos using a fine needle (Hamilton, cat.#90033). Mounted embryos or dissected fillets were photographed on a Nikon Optiphot microscope using DIC/Nomarski optics. To confirm that the in situ expression patterns described in this paper correspond to expression of single genes and were not artifacts due to the use of hybrid cDNAs, additional procedures were carried out for each cDNA. These included a second round of DNA sequencing (both 5 0 and 3 0 ), database BLAST searches, probe preparation and in situ hybridizations using new probes. In all cases 3 0 sequencing established that the cDNAs corresponded to polyadenylated transcripts and not genomic DNA contamination. Detailed protocols for embryo dissections, cDNA library preparation, and the combined RNA/protein localization are available upon request.
